PoliticalRepoPoliticalRepo

France · Question · Question écrite

20001

Question 20001 — pharmacy and medicines

openFrance· National Assembly· FR

Introduced

Last action

Status

posée

Sponsors

Subjects

Discovery layer

Source updated

Summary

Mrs. Agnès Firmin Le Bodo draws the attention of the Minister of Solidarity and Health to the shortage of medicines. Between 2016 and 2017, the number of medicines out of stock increased by more than 30%. Indeed, in 2016, 405 reports were made by pharmacists and more than 530 in 2017. The catastrophic situation that professionals have been experiencing for several weeks cannot continue, it is therefore becoming impossible to respond. provide cortisone which is an essential product for a good number of pathologies. It seems important to point out that the absence of certain medications can result in an extremely serious risk for patients, which can even become life-threatening for some. So, certainly hospitals can give back to certain patients their so-called “city” treatment but have no official directive in this sense and are similarly subject the same shortages. The senator's information report. Jean-Pierre Decool, n° 737 (2017-2018) highlights a problem concerning the waiting period for products which can be up to three months, both for so-called “common” medicines, as well as for medicines of major therapeutic interest and vaccines. Faced with this observation, several factors are pointed out, starting with the problem of approach to raw materials or the sale of medicines in countries in which their selling price is much more advantageous than in France. Furthermore, the modification of marketing authorizations but also the establishment of the just-in-time production system. The simple increase in sales volumes is, moreover, an important factor contributing to this significant shortage of medicines. As can be seen, it becomes crucial to act and launch an ambitious policy to combat drug shortages. She asks him what solutions she is considering to deal with this situation. In addition, she would like to know what resources she will be able to grant to the National Medicines Safety Agency to be the leader of this policy.

Machine translation from French. The official text remains authoritative.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.